Telithromycin for the treatment of acute bacterial maxillary sinusitis: A review of a new antibacterial agent

Southern Medical Journal

Volumn 98, Issue 9, 2005, Pages 863-868

  Tellier, Guy ^a   Brunton, Stephen A ^b   Nusrat, Roomi ^b  

^a Zoom Intl Clinical Research Group   (Canada)

^b NONE

Author keywords

Acute bacterial maxillary sinusitis; Antibiotic; Antimicrobial; Sinusitis; Telithromycin

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; ANTIBIOTIC AGENT; CEFUROXIME AXETIL; TELITHROMYCIN;

ABDOMINAL PAIN; ADOLESCENT; ADULT; AGED; ANTIMICROBIAL THERAPY; CLINICAL TRIAL; COMMUNITY CARE; CONJUNCTIVITIS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DISEASE COURSE; DIZZINESS; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; ERADICATION THERAPY; EYE PAIN; FEMALE; GASTROINTESTINAL TOXICITY; HUMAN; INFLAMMATION; LACRIMATION; MAJOR CLINICAL STUDY; MALE; MAXILLA SINUSITIS; NAUSEA; PHOTOPHOBIA; PROSPECTIVE STUDY; PRURITUS; RANDOMIZED CONTROLLED TRIAL; RESPIRATORY TRACT INFECTION; REVIEW; VISUAL IMPAIRMENT; VITREOUS BODY; VOMITING;

ACUTE DISEASE; ADOLESCENT; ADULT; AGED; AMOXICILLIN-POTASSIUM CLAVULANATE COMBINATION; ANTI-BACTERIAL AGENTS; CEFUROXIME; DOUBLE-BLIND METHOD; DRUG ADMINISTRATION SCHEDULE; FEMALE; HAEMOPHILUS INFLUENZAE; HUMANS; KETOLIDES; MALE; MAXILLARY SINUSITIS; MIDDLE AGED; MORAXELLA (BRANHAMELLA) CATARRHALIS; PROSPECTIVE STUDIES; RANDOMIZED CONTROLLED TRIALS; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS PNEUMONIAE;

EID: 25844473126     PISSN: 00384348     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.smj.0000176714.82199.23     Document Type: Review

References (33)

1. Cherry DK, Woodwell DA. National Ambulatory Medical Care Survey: 2000 summary. Adv Data 2002;328:1-32.
2. Snow V, Mottur-Pilson C, Hickner JM. Principles of appropriate antibiotic use for acute sinusitis in adults. Ann Intern Med 2001;134:495-497.
3. Lanza DC, Kennedy DW. Adult rhinosinusitis defined. Otolaryngol Head Neck Surg 1997;117:S1-S7.
4. Williams JW Jr, Simel DL, Roberts L, et al. Clinical evaluation for sinusitis: Making the diagnosis by history and physical examination. Ann Intern Med 1992;117:705-710.
5. Anon JB, Jacobs MR, Poole MD, et al. with the Sinus and Allergy Health Partnership. Antimicrobial treatment guidelines for acute bacterial rhinosinusitis. Otolaryngol Head Neck Surg 2004;130:1-45.
6. Gwaltney JM Jr. Acute community-acquired sinusitis. Clin Infect Dis 1996;23:1209-1225.
7. Sokol W. Epidemiology of sinusitis in the primary care setting: results from the 1999-2000 respiratory surveillance program. Am J Med 2001; 111(Suppl 9A):19S-24S.
8. Spector SL, Bernstein IL, Li JT, et al. Parameters for the diagnosis and management of sinusitis. J Allergy Clin Immunol 1998;102:S107-S144.
9. Brook I, Gooch WM III, Jenkins SG, et al. Medical management of acute bacterial sinusitis. Recommendations of a clinical advisory committee on pediatric and adult sinusitis. Ann Otol Rhinol Laryngol Suppl 2000;182:2-20.
10. Appelbaum PC. Resistance among Streptococcus pneumoniae: implications for drug selection. Clin Infect Dis 2002;34:1613-1620.
11. Sahm DF, Weaver MK, Flamm RK, et al. Antimicrobial susceptibility in Streptococcus pneumoniae recovered from sinus specimens: results from 2000-2003 TRUST Surveillance Studies. Paper presented at the 43rd Annual Interscience Conference on Antimicrobial Agents and Chemotherapy, Chicago, IL, Sept 14-17, 2003 (abstract C2-924).
12. Guay DRP. Short-course antimicrobial therapy for upper respiratory tract infections. Clin Ther 2000;22:673-684.
13. Leclercq R. Overcoming antimicrobial resistance: profile of a new ketolide antibacterial, telithromycin. J Antimicrob Chemother. 2001; 48(Suppl T1):9-23.
14. Adam D. Short-course antibiotic therapy for infections with a single causative pathogen. J Int Med Res 2000;28(Suppl 1):13A-24A.
15. Pechere JC. Parameters important in short antibiotic courses. J Int Med Res 2000;28(Suppl 1):3A-12A.
16. Claxton AJ, Cramer J, Pierce C. A systematic review of the associations between dose regimens and medication compliance. Clin Ther 2001;23: 1296-1310.
17. Schrag SJ, Peña C, Fernández J, et al. Effect of short-course, high-dose amoxicillin therapy on resistant pneumococcal carriage: a randomized trial. JAMA 2001;286:49-56.
18. Xiong L, Shah S, Mauvais P, et al. A ketolide resistance mutation in domain II of 23S rRNA reveals the proximity of hairpin 35 to the peptidyl transferase centre. Mol Microbiol 1999;31:633-639.
19. Douthwaite S, Hansen LH, Mauvais P. Macrolide-ketolide inhibition of MLS-resistant ribosomes is improved by alternative drug interaction with domain II of 23S rRNA. Mol Microbiol 2000;36:183-193.
20. Hansen LH, Mauvais P, Douthwaite S. The macrolide-ketolide antibiotic binding site is formed by structures in domains II and V of 23 S ribosomal RNA. Mol Microbiol 1999;31:623-631.
21. Felmingham D. Microbiological profile of telithromycin, the first ketolide antimicrobial. Clin Microbiol Infect. 2001;7(Suppl 3):2-10.
22. Fuchs PC, Barry AL, Brown SD. In vitro activity of telithromycin against Streptococcus pneumonias resistant to other antibiotics, including cefotaxime. J Antimicrob Chemother 2002;49:399-401.
23. Bearden DT, Neuhauser MM, Garey KW. Telithromycin: an oral ketolide for respiratory infections. Pharmacotherapy 2001;21:1204-1222.
24. Okamoto H, Miyazaki S, Tateda K, et al. In vivo efficacy of telithromycin (HMR 3647) against Streptococcus pneumoniae and Haemophilus influenzae. Antimicrob Agents Chemother 2001;45:3250-3252.
25. Klossek JM, Serrano E, Peynegre R, et al. Penetration of telithromycin (HMR 3647), a new ketolide, into sinus tissue in patients undergoing sinusectomy. In: Program and Abstracts of the 22nd Interdisciplinary Meeting on Anti-Infectious Chemotherapy; December 5-6, 2002; Paris, France. Abstract 33-C6.
26. Roos K, Brunswig-Pitschner C, Kostrica R, et al. Efficacy and tolerability of once-daily therapy with telithromycin for 5 or 10 days for the treatment of acute maxillary sinusitis. Chemotherapy 2002;48:100-108.
27. Luterman M, Tellier G, Lasko B, et al. Efficacy and tolerability of telithromycin for 5 or 10 days vs amoxicillin/clavulanic acid for 10 days in acute maxillary sinusitis. Ear Nose Throat J 2003;82:576-586.
28. Buchanan PP, Stephens TA, Leroy B. A comparison of the efficacy of telithromycin versus cefuroxime axetil in the treatment of acute bacterial maxillary sinusitis. Am J Rhinol 2003;17:369-377.
29. Tellier G, Rangaraju M, Leroy B, et al. Telithromycin is efficacious for the treatment of acute maxillary sinusitis in patients of special interest. Paper presented at the 43rd Annual Interscience Conference on Antimicrobial Agents and Chemotherapy, Chicago, IL, Sept 14-17, 2003 (poster L-1381).
30. Rakkar S, Roberts K, Towe BF, et al. Moxifloxacin versus amoxicillin clavulanate in the treatment of acute maxillary sinusitis: a primary care experience. Int J Clin Pract 2001;55:309-315.
31. Murray JJ, Solomon E, McCluskey D, et al. Phase III, randomized, double-blind study of clarithromycin extended-release and immediate-release formulations in the treatment of adult patients with acute maxillary sinusitis. Clin Ther 2000;22:1421-1432.
32. Henry DC, Moller DJ Jr, Adelglass J, et al. Comparison of sparfloxacin and clarithromycin in the treatment of acute bacterial maxillary sinusitis. Sparfloxacin Multicenter AMS Study Group. Clin Ther 1999;21:340-352.
33. Kem EB. Suppurative (bacterial) sinusitis. Postgrad Med 1987;81:194-210.